CULP vs NBIX · rev $203.5M vs P/E 45, rev $1.77B
Culp Inc (CULP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Culp Inc (CULP) is a textile manufacturing company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CULP revenue for 2026-05-03 was $203.5M. Net income was -$10.2M. Revenue was down 4.6% from 2025-04-27 to 2026-05-03. CULP currently screens at market cap $49.7M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
CULP currently screens at market cap $49.7M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the CULP and NBIX stock pages for the full models.
Not investment advice.